nVerses Capital »

Cytek Biosciences shares owned by nVerses Capital

Quarter-by-quarter ownership of Cytek Biosciences (CTKB) shares owned by nVerses Capital from 13F filings

Historical chart of nVerses Capital investment in Cytek Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Cytek Biosciences held by nVerses Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytek Biosciences by nVerses Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $168k 38k 4.37

More positions owned by nVerses Capital

Lam Research Corp Com New (LRCX)
Ally Financial (ALLY)
Comfort Systems USA (FIX)
Intuitive Surgical Com New (ISRG)
Cintas Corporation (CTAS)
Owl Rock Capital Corporation (OBDC)
Stryker Corporation (SYK)
Jefferies Finl Group (JEF)
Atmus Filtration Technologies Ord (ATMU)
Tsakos Energy Navigation SHS (TEN)
Docusign (DOCU)
A10 Networks (ATEN)
Domino's Pizza (DPZ)
Arista Networks Com Shs (ANET)
Cincinnati Financial Corporation (CINF)

View all positions for nVerses Capital

Top funds holding Cytek Biosciences

BlackRock
Vanguard Group
Hillhouse Capital Advisors
Millennium Management
Robeco Investment Management
Vanguard Capital Management
State Street Corporation
Geode Capital Management
Dimensional Fund Advisors
Goldman Sachs Group
Vanguard Portfolio Management
Brown Capital Management
Morgan Stanley
Royce & Associates
Russell Investments

View all funds holding Cytek Biosciences